{"transactions":[{"id":790257,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":33271,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":33271,"derivative":{"exercise_price":0.32,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":33271},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":790256,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":92683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents a right to purchase 92,683 shares of the Issuer's common stock, one quarter of which vested on November 13, 2025, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":92683,"derivative":{"exercise_price":5.98,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":92683},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":790255,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":95060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":95060,"derivative":{"exercise_price":2.34,"expiration_date":"2032-01-23","underlying":"Common Stock","underlying_shares":95060},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":790254,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":33271,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":33271,"derivative":{"exercise_price":2,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":33271},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":790253,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":11882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":11882,"derivative":{"exercise_price":2,"expiration_date":"2030-12-17","underlying":"Common Stock","underlying_shares":11882},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":790252,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":47530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":47530,"derivative":{"exercise_price":0.93,"expiration_date":"2030-01-12","underlying":"Common Stock","underlying_shares":47530},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":790251,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-07T00:38:03.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":95060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":95060,"derivative":{"exercise_price":0.32,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":95060},"source":{"system":"sec-edgar","filing":"0001140361-26-019376","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126019376/form4.xml","form_type":"4"}},{"id":1120086,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-06T20:22:46.000Z","date":"2025-06-04","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through June 4, 2026, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":26000,"derivative":{"exercise_price":8.58,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001140361-25-021793","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125021793/form4.xml","form_type":"4"}},{"id":1169164,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-18T21:27:15.000Z","date":"2025-04-16","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":299652,"derivative":{"exercise_price":6.93,"expiration_date":"2033-10-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-25-014601","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014601/form4.xml","form_type":"4"}},{"id":1169163,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-04-18T21:27:15.000Z","date":"2025-04-16","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":6.93,"value":103950.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001140361-25-014601","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014601/form4.xml","form_type":"4"}},{"id":1431652,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-17T00:58:39.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":26000,"derivative":{"exercise_price":9.98,"expiration_date":"2034-08-14","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001140361-24-037708","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036124037708/form4.xml","form_type":"4"}},{"id":1752578,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-01T10:15:33.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":1866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vest as to one-third on each of the first, second and third anniversaries of October 31, 2023, subject to the Reporting Person's continued service to the Issuer through each vesting date."}],"balance_after":1866,"derivative":{"exercise_price":6.93,"expiration_date":"2033-10-31","underlying":"Common Stock","underlying_shares":1866},"source":{"system":"sec-edgar","filing":"0001140361-23-050619","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123050619/form4.xml","form_type":"4"}},{"id":1752577,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":49434,"kind":"person","name":"Eastling Thomas Wilson","position":1,"cik":"0001958487","reported_name":"Eastling Thomas Wilson","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-01T10:15:33.000Z","date":"2023-10-31","kind":"grant","planned":false,"acquired":true,"shares":314652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are vested in full."}],"balance_after":314652,"derivative":{"exercise_price":6.93,"expiration_date":"2033-10-31","underlying":"Common Stock","underlying_shares":314652},"source":{"system":"sec-edgar","filing":"0001140361-23-050619","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036123050619/form4.xml","form_type":"4"}}]}